Effect of 1-(phenyl)-N’-(4-methoxybenzylidene)-9H-pyrido[3,4-b] indole-3-carbohydrazide on in vitro poliovirus replication

1. J. L. Melnick, Current status of poliovirus infections, Clin. Microbiol. Rev. 9 (1996) 293-300.10.1128/CMR.9.3.293Search in Google Scholar

2. B. Blondel, G. Duncan, T. Couderc, F. Delpeyroux, N. Pavio and F. Colbere-Garapin, Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells, J. Neurol. Virol. 4 (1998) 1-26; DOI: 10.3109/13550289809113478.10.3109/13550289809113478Search in Google Scholar

3. S. Muller, E. Wimmer and J. Cello, Poliovirus and poliomyelitis: A tale of guts, brain and an accidental event, Virus Res. 111 (2005) 157-193; DOI: 10.1016/j.virusres.2005.04.008.10.1016/j.virusres.2005.04.008Search in Google Scholar

4. WHO. Poliomyelitis, May 2014; h_ p://www.who.int/mediacentre/factsheets/fs114/en/; last access date August 26, 2014Search in Google Scholar

5. R. A. Tripp, Addressing the re-emergence of poliovirus, J. Antivir. Antiretrovir. 6 (2014) xxxiv-xxxv; DOI: 10.4172/jaa.1000e116.10.4172/jaa.1000e116Search in Google Scholar

6. Commi_ ee on Development of a Polio Antiviral and its Potential Role in Global Poliomyelitis Eradication, Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report. The National Academy Press, Washington 2006.Search in Google Scholar

7. B. Thys, L. Scho_ e, S. Muyldermans, U. Wernery, G. Hassanzadeh-Ghassabeh and B. Rombaut, In vitro antiviral activity of single domain antibody fragments against poliovirus, Antiviral Res. 87 (2010) 257-264; DOI: 10.1016/j.antiviral.2010.05.012.10.1016/j.antiviral.2010.05.012Search in Google Scholar

8. M. S. Colle_ , J. Neyts and J. F. Modlin. A case for developing drugs against polio, Antiviral Res. 79 (2008) 179-187; DOI: 10.1016/j.antiviral.2008.04.002.10.1016/j.antiviral.2008.04.002Search in Google Scholar

9. E. De Clercq, Highlights in antiviral drug research: antivirals at the horizon, Med. Res. Rev. (2012) 1215-1248; DOI: 10.1002/med.21256.10.1002/med.21256Search in Google Scholar

10. J. G. Tang, Y. H. Wang, R. R. Wang, Z. J. Dong, L. M. Yang, Y. T. Zheng and J. K. Liu, Synthesis of analogues of flazin, in particular, flazinamide, as promising anti-HIV agents, Chem. Biodivers. 5 (2008) 447-460; DOI: 10.1002/cbdv.200890044. 10.1002/cbdv.200890044Search in Google Scholar

11. J. H. V. Maarseveen, H. W. Cheeren, E. D. Clerq, J. Balzarini and C. G. Kruse, Antiviral and tumor cell antiproliferative SAR studies on tetracyclic eudistomins-II, Bioorg. Med. Chem. 5 (1997) 955-970; DOI: 10.1016/S0968-0896(97)00034-5.10.1016/S0968-0896(97)00034-5Search in Google Scholar

12. J. F. Miller, E. M. Turner, R. G. Sherrill, K. Gudmundsson, A. Spaltenstein, P. Sethna, K. W. Brown, R. Harvey, K. R. Romines and P. Golden, Substituted tetrahydro-b-carbolines as potential agents for the treatment of human papillomavirus infection, Bioorg. Med. Chem. Le_ . 20 (2010) 256-259; DOI: 10.1016/j.bmcl.2009.10.123.10.1016/j.bmcl.2009.10.12319914830Search in Google Scholar

13. A. S. N. Formagio, P. R. Santos, K. Zanoli, T. Ueda-Nakamura, L. T. Dusman Tonin, C. V. Nakamura and M. H. Sarragio_ o, Synthesis and antiviral activity of b-carboline derivatives bearing a substituted carbohydrazide at C-3 against poliovirus and herpes simplex virus (HSV-1), Eur. J. Med. Chem. 44 (2009) 4695-4701; DOI: 10.1016/j.ejmech.2009.07.005.10.1016/j.ejmech.2009.07.00519647908Search in Google Scholar

14. I. Camargo Filho, D. A. G. Cortez, T. Ueda-Nakamura, C. V. Nakamura and B. P. Dias Filho, Antiviral activity and mode of action of a peptide isolated from Sorghum bicolor, Phytomedicine 15 (2008) 202-208; DOI: 10.1016/j.phymed.2007.07.059.10.1016/j.phymed.2007.07.05917890069Search in Google Scholar

15. P. Skehan, R. Storeng, A. Scudeiro Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/83.13.1107. Search in Google Scholar